Research theme for competitive and other funds (5):
2023 - 2026 Establishment of the combined treatment of hematopoietic stem cells transplantation and S100A6 inhibitors to KMT2A/AFF1 positive acute lymphoblastic leukemia
Hayato Tamai, Kenji Tajika, Kazutaka Nakayama, Ayako Arai. Treatment of relapsed aggressive adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation with mogamulizumab followed by lenalidomide. Bone Marrow Transplantation. 2021